Search research articles
Contact Us
Filters
Showing results (311-320 of 365) with videos related to
Page
of 37
Sort By:
Journal of the American College of Surgeons
|
February 12, 2018
Reducing Early Readmissions after Ventral Hernia Repair with the Americas Hernia Society Quality Collaborative
Benjamin K Poulose, DeAngelo A Harris, Sharon Phillips, et al.
The Pediatric Infectious Disease Journal
|
May 16, 2018
Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials
Laura L Kovanda, Thomas J Walsh, Daniel K Benjamin, et al.
Antimicrobial Agents and Chemotherapy
|
May 8, 2019
Population Pharmacokinetics of Anidulafungin in Critically Ill Patients
S Luque, W Hope, N Campillo, et al.
The Journal of Infectious Diseases
|
May 29, 2012
Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints
Adam R Jeans, Susan J Howard, Zaid Al-Nakeeb, et al.
The Journal of Antimicrobial Chemotherapy
|
April 29, 2016
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial
William W Hope, Thomas J Walsh, Joanne Goodwin, et al.
Antimicrobial Agents and Chemotherapy
|
October 9, 2019
Amphotericin B Penetrates into the Central Nervous System Through Focal Disruption of the Blood Brain Barrier in Experimental Hematogenous <i>Candida</i> Meningoencephalitis
Vidmantas Petraitis, Ruta Petraitiene, Jessica M Valdez, et al.
Open Forum Infectious Diseases
|
December 22, 2021
Exploring the Pharmacokinetics of Phenoxymethylpenicillin (Penicillin-V) in Adults: A Healthy Volunteer Study
Timothy M Rawson, Richard C Wilson, Luke S P Moore, et al.
Antimicrobial Agents and Chemotherapy
|
April 11, 2013
Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints
Ajay Sudan, Joanne Livermore, Susan J Howard, et al.
Antimicrobial Agents and Chemotherapy
|
July 20, 2007
Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing
William W Hope, Nita L Seibel, Cindy L Schwartz, et al.
The Pediatric Infectious Disease Journal
|
March 30, 2018
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
Daniel K Benjamin, David A Kaufman, William W Hope, et al.
Page
of 37
Search research articles
Search
Showing results (311-320 of 365) with videos related to
Sort By:
Page
of 37
Journal of the American College of Surgeons
|
February 12, 2018
Reducing Early Readmissions after Ventral Hernia Repair with the Americas Hernia Society Quality Collaborative
Benjamin K Poulose, DeAngelo A Harris, Sharon Phillips, et al.
The Pediatric Infectious Disease Journal
|
May 16, 2018
Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials
Laura L Kovanda, Thomas J Walsh, Daniel K Benjamin, et al.
Antimicrobial Agents and Chemotherapy
|
May 8, 2019
Population Pharmacokinetics of Anidulafungin in Critically Ill Patients
S Luque, W Hope, N Campillo, et al.
The Journal of Infectious Diseases
|
May 29, 2012
Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints
Adam R Jeans, Susan J Howard, Zaid Al-Nakeeb, et al.
The Journal of Antimicrobial Chemotherapy
|
April 29, 2016
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial
William W Hope, Thomas J Walsh, Joanne Goodwin, et al.
Antimicrobial Agents and Chemotherapy
|
October 9, 2019
Amphotericin B Penetrates into the Central Nervous System Through Focal Disruption of the Blood Brain Barrier in Experimental Hematogenous <i>Candida</i> Meningoencephalitis
Vidmantas Petraitis, Ruta Petraitiene, Jessica M Valdez, et al.
Open Forum Infectious Diseases
|
December 22, 2021
Exploring the Pharmacokinetics of Phenoxymethylpenicillin (Penicillin-V) in Adults: A Healthy Volunteer Study
Timothy M Rawson, Richard C Wilson, Luke S P Moore, et al.
Antimicrobial Agents and Chemotherapy
|
April 11, 2013
Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints
Ajay Sudan, Joanne Livermore, Susan J Howard, et al.
Antimicrobial Agents and Chemotherapy
|
July 20, 2007
Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing
William W Hope, Nita L Seibel, Cindy L Schwartz, et al.
The Pediatric Infectious Disease Journal
|
March 30, 2018
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
Daniel K Benjamin, David A Kaufman, William W Hope, et al.
Page
of 37